SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043442
Filing Date
2021-08-11
Accepted
2021-08-11 16:16:43
Documents
75
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cccc-10q_20210630.htm   iXBRL 10-Q 2965998
2 EX-31.1 cccc-ex311_6.htm EX-31.1 20650
3 EX-31.2 cccc-ex312_8.htm EX-31.2 20661
4 EX-32.1 cccc-ex321_9.htm EX-32.1 9381
5 EX-32.2 cccc-ex322_7.htm EX-32.2 9278
  Complete submission text file 0001564590-21-043442.txt   9253855

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cccc-20210630.xsd EX-101.SCH 64792
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cccc-20210630_cal.xml EX-101.CAL 54870
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cccc-20210630_def.xml EX-101.DEF 153141
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cccc-20210630_lab.xml EX-101.LAB 443224
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cccc-20210630_pre.xml EX-101.PRE 327671
11 EXTRACTED XBRL INSTANCE DOCUMENT cccc-10q_20210630_htm.xml XML 1644208
Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39567 | Film No.: 211163627
SIC: 2836 Biological Products, (No Diagnostic Substances)